G
Grant Luxton
Researcher at University of New South Wales
Publications - 14
Citations - 1072
Grant Luxton is an academic researcher from University of New South Wales. The author has contributed to research in topics: Dialysis & Randomized controlled trial. The author has an hindex of 8, co-authored 12 publications receiving 954 citations. Previous affiliations of Grant Luxton include University of Sydney & Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis
Bruce A. Cooper,Pauline Branley,Liliana Bulfone,John F. Collins,Jonathan C. Craig,Margaret B. Fraenkel,Anthony Harris,David W. Johnson,Joan Kesselhut,Jing Jing Li,Grant Luxton,Andrew Pilmore,David J. Tiller,David Harris,Carol A. Pollock +14 more
TL;DR: In this article, the authors examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease and found no significant difference between the groups in the frequency of adverse events, infections, or complications of dialysis.
Journal ArticleDOI
Cost-Effectiveness of Initiating Dialysis Early: A Randomized Controlled Trial
Anthony Harris,Bruce A. Cooper,Jing Jing Li,Liliana Bulfone,Liliana Bulfone,Pauline Branley,John F. Collins,Jonathan C. Craig,Margaret B. Fraenkel,David W. Johnson,Joan Kesselhut,Grant Luxton,Andrew Pilmore,Martin Rosevear,David J. Tiller,Carol A. Pollock,David Harris +16 more
TL;DR: Planned early initiation of dialysis therapy in patients with progressive chronic kidney disease has higher dialysis costs and is not associated with improved quality of life.
Journal ArticleDOI
The Initiating Dialysis Early and Late (IDEAL) study: study rationale and design
Bruce A. Cooper,Bruce A. Cooper,Pauline Branley,Liliana Bulfone,John F. Collins,Jonathan C. Craig,Jenny Dempster,Margaret B. Fraenkel,Anthony Harris,David Harris,David W. Johnson,Joan Kesselhut,Grant Luxton,Andrew Pilmore,Carol A. Pollock,David J. Tiller +15 more
TL;DR: The IDEAL study will provide evidence for the optimal time to commence dialysis and determine the impact of “early start’ versus “late start” dialysis on nutritional and cardiac morbidity, quality of life, and economic cost.
Journal ArticleDOI
Infliximab and nephrotic syndrome
TL;DR: A probable case of infliximab-induced membranous nephropathy is described, which appears to be effective in patients with rheumatoid arthritis and inflammatory bowel disease and in other conditions such as psoriasis and ankylosing spondylitis.
Journal ArticleDOI
Effect of Timing of Dialysis Commencement on Clinical Outcomes of Patients with Planned Initiation of Peritoneal Dialysis in the Ideal Trial
David W. Johnson,Muh Geot Wong,Bruce A. Cooper,Pauline Branley,Liliana Bulfone,John F. Collins,Jonathan C. Craig,Margaret B. Fraenkel,Anthony Harris,Joan Kesselhut,Jing Jing Li,Grant Luxton,Andrew Pilmore,David J. Tiller,David Harris,Carol A. Pollock +15 more
TL;DR: Early initiation of dialysis in patients with stage 5 chronic kidney disease who planned to be treated with peritoneal dialysis with PD was associated with clinical outcomes comparable to those seen with late dialysis initiation.